Darnell A. Pouncil

Array ( [id] => 11277071 [patent_doc_number] => 09493548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Immunoglobulin purification' [patent_app_type] => utility [patent_app_number] => 12/599703 [patent_app_country] => US [patent_app_date] => 2008-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9624 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12599703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464424 [patent_doc_number] => 20090324624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Chitin micro-particles as an adjuvant' [patent_app_type] => utility [patent_app_number] => 12/152392 [patent_app_country] => US [patent_app_date] => 2008-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15022 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0324/20090324624.pdf [firstpage_image] =>[orig_patent_app_number] => 12152392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820494 [patent_doc_number] => 20080226647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Monoclonal Antibodies Against The Interferon Receptor, With Neutralizing Activity Against Type I Interferon' [patent_app_type] => utility [patent_app_number] => 12/118010 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5049 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226647.pdf [firstpage_image] =>[orig_patent_app_number] => 12118010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4739939 [patent_doc_number] => 20080233592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Assay Method for Group Transfer Reactions' [patent_app_type] => utility [patent_app_number] => 12/109628 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 27500 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233592.pdf [firstpage_image] =>[orig_patent_app_number] => 12109628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6145218 [patent_doc_number] => 20110130544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'ANTIBODIES WITH DECREASED DEAMIDATION PROFILES' [patent_app_type] => utility [patent_app_number] => 12/593767 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33356 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130544.pdf [firstpage_image] =>[orig_patent_app_number] => 12593767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6504255 [patent_doc_number] => 20100260766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'STABLE ANTIBODY FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/528882 [patent_app_country] => US [patent_app_date] => 2008-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14566 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20100260766.pdf [firstpage_image] =>[orig_patent_app_number] => 12528882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710608 [patent_doc_number] => 20080299134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'Recombinant Anti-Interleukin-9 Antibodies' [patent_app_type] => utility [patent_app_number] => 12/049566 [patent_app_country] => US [patent_app_date] => 2008-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 44254 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299134.pdf [firstpage_image] =>[orig_patent_app_number] => 12049566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820509 [patent_doc_number] => 20080226650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'COTININE NEUTRALIZING ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/048636 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5065 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226650.pdf [firstpage_image] =>[orig_patent_app_number] => 12048636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839834 [patent_doc_number] => 20080280320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Formulation of antigen' [patent_app_type] => utility [patent_app_number] => 12/070676 [patent_app_country] => US [patent_app_date] => 2008-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2156 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280320.pdf [firstpage_image] =>[orig_patent_app_number] => 12070676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10863428 [patent_doc_number] => 08889117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'Modular nanoparticles for adaptable vaccines' [patent_app_type] => utility [patent_app_number] => 12/527143 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 15702 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12527143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4872751 [patent_doc_number] => 20080199485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Method for enhancing T cell response' [patent_app_type] => utility [patent_app_number] => 12/070156 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19029 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20080199485.pdf [firstpage_image] =>[orig_patent_app_number] => 12070156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9216451 [patent_doc_number] => 08629250 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-14 [patent_title] => 'Hepcidin, hepcidin antagonists and methods of use' [patent_app_type] => utility [patent_app_number] => 12/022515 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 54 [patent_no_of_words] => 58825 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12022515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508037 [patent_doc_number] => 20090081244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Dry Formulation for Transcutaneous Immunization' [patent_app_type] => utility [patent_app_number] => 12/019798 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 47135 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081244.pdf [firstpage_image] =>[orig_patent_app_number] => 12019798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4825008 [patent_doc_number] => 20080124350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Nanoparticle-based vaccine delivery system containing adjuvant' [patent_app_type] => utility [patent_app_number] => 12/010468 [patent_app_country] => US [patent_app_date] => 2008-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7355 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124350.pdf [firstpage_image] =>[orig_patent_app_number] => 12010468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 33111 [patent_doc_number] => 07790859 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors' [patent_app_type] => utility [patent_app_number] => 11/962594 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 27 [patent_no_of_words] => 30577 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790859.pdf [firstpage_image] =>[orig_patent_app_number] => 11962594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4873918 [patent_doc_number] => 20080200652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Novel Cherkasky fusion proteins containing antibody binding proteins or the regions thereof' [patent_app_type] => utility [patent_app_number] => 12/003272 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4464 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200652.pdf [firstpage_image] =>[orig_patent_app_number] => 12003272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4697844 [patent_doc_number] => 20080220028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'ARCHAEAL POLAR LIPID AGGREGATES FOR ADMINISTRATION TO ANIMALS' [patent_app_type] => utility [patent_app_number] => 11/956653 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 34891 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20080220028.pdf [firstpage_image] =>[orig_patent_app_number] => 11956653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786463 [patent_doc_number] => 20080139792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'High Protein Concentration Formulations Containing Mannitol' [patent_app_type] => utility [patent_app_number] => 11/950986 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 4432 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139792.pdf [firstpage_image] =>[orig_patent_app_number] => 11950986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 173549 [patent_doc_number] => 07658928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptide' [patent_app_type] => utility [patent_app_number] => 11/947729 [patent_app_country] => US [patent_app_date] => 2007-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 11578 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/658/07658928.pdf [firstpage_image] =>[orig_patent_app_number] => 11947729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6348824 [patent_doc_number] => 20100021486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'TSLP VACCINE FOR THE TREATMENT OF TH2 MEDIATED INFLAMMATORY CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/312812 [patent_app_country] => US [patent_app_date] => 2007-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2004 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021486.pdf [firstpage_image] =>[orig_patent_app_number] => 12312812 [rel_patent_id] =>[rel_patent_doc_number] =>)